Sign in

CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company

Akari Therapeutics Plc

Sign in to watch
Ticker
AKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
EIN
981034922
Phone
(929) 274-7510
Business address
401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
Former names
Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
  1. 8-K Event Regulation FD disclosure
  2. 4 Grant or award Director acquired 8,000,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,720,000 shares (grant or award)
  4. 4 Grant or award Director acquired 208,000 shares (grant or award)
  5. 4 Grant or award Director acquired 3,600,000 shares (grant or award)
  6. 4 Grant or award Director acquired 40,000,000 shares (grant or award)
  7. 4 Grant or award Director acquired 30,000,000 shares (grant or award)
  8. 4 Grant or award Director acquired 7,500,000 shares (grant or award)
  9. 4 Grant or award Director acquired 2,000,000 shares (grant or award)
  10. 4 Grant or award Director acquired 1,400,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 1,400,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. 8-K Event Executive or director change
  16. 8-K Event Executive or director change
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 4 Grant or award Director acquired 419,286,000 shares (grant or award)
  19. 4 Grant or award Director acquired 419,286,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 8 of 38 · 746 filings